#1 Clinical Trials Search in Europe

Potassium Chloride

Potassium chloride, a common electrolyte supplement, is being investigated in several clinical trials for its potential benefits in treating various medical conditions. These trials aim to explore its effectiveness in managing cardiac arrests, regulating potassium levels in intensive care patients, preventing contrast-induced nephropathy, and addressing metabolic acidosis in renal transplant patients. The research seeks to determine optimal administration methods and dosages to improve patient outcomes across different medical scenarios.

Table of Contents

What is Potassium Chloride?

Potassium chloride is a medication used to treat and prevent low potassium levels in the blood, a condition known as hypokalemia. It is an essential mineral that plays a crucial role in various bodily functions, including heart rhythm, muscle contractions, and nerve signaling[1].

Potassium chloride is also known by its chemical formula KCl and is classified as an electrolyte supplement[1]. It’s important to note that potassium levels in the body need to be carefully balanced, as both low and high levels can cause serious health problems.

Medical Uses of Potassium Chloride

Potassium chloride is primarily used to treat and prevent hypokalemia. This condition can occur due to various reasons, including:

  • Certain medications (e.g., diuretics)
  • Excessive sweating or fluid loss
  • Kidney problems
  • Certain heart conditions

In addition to treating hypokalemia, potassium chloride is used in specific medical scenarios:

  1. Cardiac Surgery: It’s often used in pediatric cardiac intensive care units to manage potassium levels after heart surgery[2].
  2. Contrast-Induced Nephropathy Prevention: Some research is exploring its use in preventing kidney damage caused by contrast agents used in certain medical imaging procedures[3].
  3. Brain-Dead Organ Donors: It’s being studied for use in maintaining organ function in brain-dead organ donors[4].

How is Potassium Chloride Administered?

Potassium chloride can be administered in several ways, depending on the patient’s condition and the healthcare setting:

  1. Oral Supplements: These are often used for mild cases of hypokalemia or for maintenance therapy. They come in various forms such as tablets, capsules, or liquid[2].
  2. Intravenous (IV) Infusion: This method is commonly used in hospital settings, especially for patients who cannot take oral medications or who need rapid correction of potassium levels. It can be given as:
    • Continuous infusion: A steady, slow infusion over time
    • Intermittent infusion: Larger doses given at intervals
    The choice between these methods often depends on the severity of hypokalemia and the patient’s overall condition[1].

The dosage and administration method are carefully determined by healthcare providers based on the patient’s potassium levels, kidney function, and other factors.

Safety and Side Effects

While potassium chloride is an essential medication, it requires careful monitoring due to potential risks:

  • Hyperkalemia: Excessive potassium levels can be dangerous and potentially lead to heart rhythm problems[1].
  • Gastrointestinal Issues: Oral potassium supplements can cause stomach upset, nausea, vomiting, or diarrhea[2].
  • Cardiac Arrhythmias: Rapid changes in potassium levels can affect heart rhythm[1].

Due to these potential risks, potassium chloride is often considered a “high-alert medication,” especially when given intravenously. This means that extra precautions are taken to ensure its safe use[2].

Current Research and Clinical Trials

Several ongoing clinical trials are exploring new uses and administration methods for potassium chloride:

  1. Contrast-Induced Nephropathy Prevention: A study is investigating whether potassium nitrate (a related compound) can help prevent kidney damage caused by contrast agents used in coronary angiography procedures[3].
  2. Brain-Dead Organ Donors: Researchers are studying the use of potassium canrenoate (another potassium-based medication) in maintaining organ function in brain-dead organ donors[4].
  3. Comparison of Administration Methods: Studies are comparing the effectiveness and safety of different potassium chloride administration methods, such as continuous IV infusion versus intermittent infusion, and oral versus IV administration[1][2].

These studies aim to improve our understanding of how to use potassium chloride most effectively and safely in various medical situations.

Trial ID Condition Intervention Primary Outcome
NCT04316611 Out-of-hospital Cardiac Arrest Intravenous potassium chloride Survival at hospital admission
NCT01085071 Thoracic Surgery Continuous potassium chloride infusion Incidence of atrial fibrillation or flutter
NCT03627130 Contrast-induced Nephropathy Oral potassium chloride (placebo) Development of contrast-induced nephropathy
NCT02015962 Acute Hypokalemia Intravenous vs. oral potassium chloride Change in serum potassium levels
NCT00913796 Metabolic Acidosis in Renal Transplant Patients Oral potassium chloride Correction of metabolic acidosis

FAQ

  • What is the purpose of using potassium chloride in out-of-hospital cardiac arrest cases? In the NCT04316611 trial, potassium chloride is being evaluated for its potential to improve survival rates in patients experiencing out-of-hospital cardiac arrest due to refractory ventricular fibrillation. The study aims to assess if a direct intravenous injection of 20 mmol potassium chloride can increase survival rates upon hospital arrival.
  • How is potassium chloride being used to regulate potassium levels in intensive care patients? The NCT01085071 trial compares two different potassium target values (4.0 mmol/L vs 4.5 mmol/L) in intensive care patients. Potassium chloride is administered continuously and titrated to achieve these target levels, with the aim of determining the optimal potassium range for preventing complications like atrial fibrillation.
  • What role does potassium chloride play in the prevention of contrast-induced nephropathy? In the NCT03627130 study, potassium chloride serves as a placebo comparator to potassium nitrate. The trial aims to investigate whether dietary inorganic nitrate therapy can prevent contrast-induced nephropathy in patients undergoing coronary angiography for acute coronary syndrome.
  • How is potassium chloride administration being compared to other methods of potassium supplementation? The NCT02015962 trial compares enteral (oral) versus intravenous potassium supplementation in treating hypokalemia in pediatric cardiac intensive care patients. This study aims to determine if oral potassium chloride can be as effective as intravenous administration.
  • What is the purpose of using potassium chloride in renal transplant patients with metabolic acidosis? In the NCT00913796 study, potassium chloride is used as an active comparator to potassium citrate. The trial aims to investigate the effects of correcting metabolic acidosis on physical capacity, bone structure, and mineral metabolism in renal transplant patients.

Ongoing Clinical Trials on Potassium Chloride

  • Study on the Safety and Effectiveness of Cenegermin Eye Drops for Patients with Dry Eye Disease

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study on Andexanet Alfa for Patients on Factor Xa Inhibitors (Apixaban, Rivaroxaban, Edoxaban) Needing Urgent Surgery to Reduce Bleeding Risk

    Not recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Estonia +13

  • Study on Pravastatin’s Effect on Insulin Resistance in Kidney Transplant and Chronic Kidney Disease Patients

    Not recruiting

    1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Spinal vs. General Anaesthesia with Ropivacaine Hydrochloride for Osteoarthritis Patients Undergoing Hip and Knee Replacement

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Early vs. Delayed Supplementary Parenteral Nutrition with SmofKabiven for Patients After Major Emergency Abdominal Surgery

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

  • Study on Liver Transplantation: Comparing Custodiol-N Solution with a Drug Combination for Organ Preservation in Patients Undergoing Liver Transplant Surgery

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • Ventricular Fibrillation: A life-threatening heart rhythm disorder where the lower chambers of the heart quiver instead of beating effectively, leading to cardiac arrest if not treated promptly.
  • Contrast-induced Nephropathy (CIN): A form of acute kidney injury that occurs after the administration of contrast media during imaging procedures, potentially leading to kidney damage.
  • Hypokalemia: A condition characterized by low levels of potassium in the blood, which can cause muscle weakness, irregular heartbeats, and other health issues.
  • Metabolic Acidosis: A condition where the body produces too much acid or cannot remove enough acid, leading to an imbalance in the body's pH levels.
  • Atrial Fibrillation (AFib): An irregular and often rapid heart rate that can increase the risk of stroke, heart failure, and other heart-related complications.
  • Transcatheter Aortic Valve Replacement (TAVR): A minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis).
  • Renal Transplantation: A surgical procedure where a healthy kidney from a donor is placed into a person whose kidneys no longer function properly.
  • Enteral Administration: The delivery of nutrients or medications directly into the digestive tract, typically through the mouth or a feeding tube.
  • Intravenous Administration: The delivery of fluids or medications directly into a vein using a needle or tube.
  • Electrolyte: Minerals in the blood and other bodily fluids that carry an electric charge and are essential for various bodily functions, including maintaining proper hydration and nerve and muscle function.

References

  1. https://clinicaltrials.gov/study/NCT00718068
  2. https://clinicaltrials.gov/study/NCT02015962
  3. https://clinicaltrials.gov/study/NCT03627130
  4. https://clinicaltrials.eu/trial/study-on-the-effects-of-potassium-canrenoate-and-trometamol-on-blood-flow-in-brain-dead-organ-donors/